Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study.

PubWeight™: 1.52‹?› | Rank: Top 4%

🔗 View Article (PMID 7673014)

Published in Int J Radiat Oncol Biol Phys on September 30, 1995

Authors

C Jaulerry1, B Dubray, F Brunin, J Rodriguez, D Point, B Blaszka, B Asselain, V Mosseri, J Brugere, J M Cosset

Author Affiliations

1: Department of Radiotherapy, Institut Curie, Paris, France.

Articles citing this

Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol (2010) 1.42

Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck. Transl Oncol (2008) 1.09

Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: a retrospective study. BMC Cancer (2014) 0.85

Comparison between radiation-induced cell cycle delay in lymphocytes and radiotherapy response in head and neck cancer. Br J Cancer (1998) 0.82

Prediction and monitoring of the response to chemoradiotherapy in oral squamous cell carcinomas using a pharmacokinetic analysis based on the dynamic contrast-enhanced MR imaging findings. Eur Radiol (2011) 0.79

Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot study. NMR Biomed (2015) 0.77

Prognostic value of tumor regression during radiotherapy or chemoradiotherapy for advanced head and neck cancers: regarding Jaulerry et al. IJROBP 33(2):271-279; 1995. Int J Radiat Oncol Biol Phys (1996) 0.75

Radiation therapy for nasopharyngeal carcinoma: the predictive value of interim survival assessment. J Radiat Res (2016) 0.75

Lesion regression rate based on RECIST: prediction of treatment outcome in patients with head and neck cancer treated with chemoradiotherapy compared with FDG PET-CT. J Radiat Res (2015) 0.75

Articles by these authors

Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie. Lancet (1992) 5.49

Age as prognostic factor in premenopausal breast carcinoma. Lancet (1993) 4.31

The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol (2001) 3.31

Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer (1996) 2.95

Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys (2000) 2.58

Cell wall composition of the yeast and mycelial forms of Paracoccidioides brasiliensis. J Bacteriol (1969) 2.50

Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res (1999) 2.23

Epidemiologic features of diabetes mellitus among Indians in northwestern Ontario and northeastern Manitoba. Can Med Assoc J (1985) 2.20

Association of p53 mutations with short survival in colorectal cancer. Gastroenterology (1994) 2.19

Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care (2001) 2.16

Incidence of vitreoretinal pathologic conditions within 24 months after laser in situ keratomileusis. Ophthalmology (2000) 2.16

Primary hepatic lymphoma: favorable outcome after combination chemotherapy. Cancer (2001) 2.08

Survival and acquired genetic alterations in colorectal cancer. Gastroenterology (1992) 2.02

Application of the LQ model to the interpretation of absorbed dose distribution in the daily practice of radiotherapy. Radiother Oncol (1991) 2.01

Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers. Br J Cancer (1996) 1.97

Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood (1991) 1.88

Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock (1995) 1.84

The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis. Br J Cancer (1998) 1.75

Role of ligaments and facets in lumbar spinal stability. Spine (Phila Pa 1976) (1995) 1.74

ICRP publication 112. A report of preventing accidental exposures from new external beam radiation therapy technologies. Ann ICRP (2009) 1.73

Cosmetic sequelae after conservative treatment for breast cancer: classification and results of surgical correction. Ann Plast Surg (1998) 1.72

Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J Natl Cancer Inst (1998) 1.71

Familial invasive breast cancers: worse outcome related to BRCA1 mutations. J Clin Oncol (2000) 1.71

Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. J Clin Oncol (2005) 1.70

Food allergy in adulthood. Allergy (2003) 1.67

Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys (1989) 1.61

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. Eur J Cancer (1994) 1.60

Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival. Int J Radiat Oncol Biol Phys (1993) 1.60

Multi-state Markov models in cancer screening evaluation: a brief review and case study. Stat Methods Med Res (2010) 1.60

Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of beta-catenin. J Cell Biol (1997) 1.60

Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer. Lancet (2001) 1.58

Albendazole therapy for neurocysticercosis. Arch Intern Med (1987) 1.58

How, when, and why bile duct injury occurs. A comparison between open and laparoscopic cholecystectomy. Surg Endosc (1998) 1.57

Polarized gamma-ray emission from the galactic black hole Cygnus X-1. Science (2011) 1.56

Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer (1996) 1.55

Modulated high-energy gamma-ray emission from the microquasar Cygnus X-3. Science (2009) 1.55

Mycelial phase of Paracoccidioides brasiliensis and Blastomyces dermatitidis: an electron microscope study. J Bacteriol (1968) 1.55

ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol (2013) 1.51

External radiotherapy for carcinoma of the eyelid: report of 850 cases treated. Int J Radiat Oncol Biol Phys (1996) 1.50

Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial. Neurology (2006) 1.47

Radiotherapy after ovarian transposition: ovarian function and fertility preservation. Int J Radiat Oncol Biol Phys (1993) 1.44

Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. J Clin Oncol (2000) 1.44

T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease. Am J Surg Pathol (1996) 1.42

Oncogene-dependent apoptosis is mediated by caspase-9. Proc Natl Acad Sci U S A (1998) 1.42

Protracted continuous infusion of 5-fluorouracil in combination with doxorubicin, vincristine, and oral cyclophosphamide in advanced breast cancer. Cancer Invest (1996) 1.42

Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br J Cancer (1995) 1.41

[First comparisons with laser vibrometry measurements and computer simulation of ear ossicle movements]. HNO (1997) 1.40

Mycoplasmal infections prevent apoptosis and induce malignant transformation of interleukin-3-dependent 32D hematopoietic cells. Mol Cell Biol (1999) 1.40

A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: clinical and treatment parameters as prognostic factors. Radiother Oncol (1989) 1.40

HDR versus LDR gynecological brachytherapy revisited. Radiother Oncol (1993) 1.40

Induction chemotherapy in advanced head and neck tumors: results of two randomized trials. Int J Radiat Oncol Biol Phys (1992) 1.40

Chemoradiotherapy for localized non-Hodgkin's lymphoma. N Engl J Med (1998) 1.39

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification. Br J Cancer (2007) 1.39

A new 123I-MIBG whole body scan scoring method--application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma. Eur J Cancer (1995) 1.38

Breast cancer in elderly women: a retrospective analysis of combined treatment with tamoxifen and once-weekly irradiation. Int J Radiat Oncol Biol Phys (1995) 1.38

[Esophageal cancer: did combined treatments improve prognosis?]. Bull Cancer (1992) 1.38

Modelling the effect of breast cancer screening on related mortality using French data. Cancer Epidemiol (2010) 1.37

Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol (1995) 1.32

Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems. Anticancer Res (1998) 1.32

M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes? J Cell Biochem (1992) 1.31

A regression survival model for testing the proportional hazards hypothesis. Biometrics (1996) 1.27

Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer (1995) 1.25

Neurocytoma of spinal cord. Acta Neuropathol (1994) 1.25

Individualising gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring strategies. Clin Pharmacokinet (1991) 1.23

Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER. Invest Ophthalmol Vis Sci (2001) 1.21

Fusarium oxysporum endophthalmitis. Arch Ophthalmol (1979) 1.21

Treatment of chronic Chagas' disease with itraconazole and allopurinol. Am J Trop Med Hyg (1998) 1.21

Update on the evaluation of hypersensitivity reactions to betalactams. Allergy (2009) 1.21

Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology (1994) 1.19

Outbreak of Clostridium difficile-related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics. J Hosp Infect (2003) 1.19

Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy. Cancer (2001) 1.17

Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis. Cancer (1988) 1.17

Effects of polychlorinated biphenyls (PCBs) on in vitro fertilization in the mouse. Reprod Toxicol (1994) 1.16

Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen. Cancer (1996) 1.16

Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: a randomized study of 151 patients. Ophthalmic Res (2006) 1.15

Penaeidins, a new family of antimicrobial peptides isolated from the shrimp Penaeus vannamei (Decapoda). J Biol Chem (1997) 1.15

Automatic definition of recurrent local structure motifs in proteins. J Mol Biol (1990) 1.14

Reproductive toxicity of Aroclor-1254: effects on oocyte, spermatozoa, in vitro fertilization, and embryo development in the mouse. Reprod Toxicol (1995) 1.14

Phylogenetic differentiation of two closely related Nitrosomonas spp. That inhabit different sediment environments in an oligotrophic freshwater lake. Appl Environ Microbiol (1999) 1.14

Validation of the EORTC QLQ-SAT32 cancer inpatient satisfaction questionnaire by self- versus interview-assessment comparison. Patient Educ Couns (2004) 1.14

Portable microsensors based on individual SnO2 nanowires. Nanotechnology (2007) 1.13

Properties and ontogenic development of membrane-bound histidine decarboxylase from rat brain. J Neurochem (1988) 1.13

Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer (2008) 1.13

Crystal structure of Apaf-1 caspase recruitment domain: an alpha-helical Greek key fold for apoptotic signaling. J Mol Biol (1999) 1.13

A model to assess the usefulness of performance indicators. Int J Qual Health Care (1996) 1.12

Health service use by African Americans and Caucasians with asthma in a managed care setting. Am J Respir Crit Care Med (1998) 1.12

Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells? J Cell Biochem (1990) 1.12

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer. Br J Cancer (2000) 1.12

Cytogenetic study of breast cancer: clinicopathologic significance of homogeneously staining regions in 84 patients. Hum Pathol (1992) 1.12